SpO2 Accuracy of Noninvasive Disposable Pulse Oximeter Sensor

Not Applicable

Completed

Brief Summary: The purpose of this clinical study is to validate the SpO2 accuracy of the Stryker Sustainability Solutions pulse oximetry sensors during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. The end goal is to provide supporting documentation for the SpO2 accuracy validation of the reprocessed sensors.

Detailed Description: In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the participant breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.

It is required that the Accuracy Root Mean Square (ARMS) performance of the Stryker pulse oximetry sensors will meet a specification of +/-3% or better in non-motion conditions for the range of 70 - 100% SaO2 (typically, saturation is determined once with air breathing and then at one of 3 levels, e.g. 95%, 85%, and 75% saturation for about 30-60 seconds at each level), thereby demonstrating an acceptable SpO2 accuracy performance specification.

Recruitment & Eligibility

Inclusion Criteria

Good general health with no evidence of pre-existing medical problems
Fluent in both written and spoken English
Must be able to review informed consent and is willing to comply with study procedures

Exclusion Criteria

Obesity (BMI >30)
Known history of heart disease, lung disease, kidney or liver disease
Prior diagnosis of asthma, sleep apnea, or use of CPAP
Diabetes
Clotting disorder
Hemoglobinopathy or history of anemia that in the opinion of the investigators would make them unsuitable for study participation
Any serious systemic illness
Current smoker
Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigator would interfere with the sensors working correctly
History of fainting or vasovagal response
History of sensitivity to local anesthesia
Prior diagnosis of Raynaud's disease
Unacceptable collateral circulation based on exam by investigators (Allen's test)
Pregnant, lactating, or trying to get pregnant
Unable or unwilling to provide informed consent, or unable or unwilling to comply with study procedures
Any other condition which in the opinion of the investigators would make them unsuitable for the study

Arm && Interventions

Group	Intervention	Description
Healthy adult participants	STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERS	All participants are enrolled in the test group and receive the noninvasive adhesive reprocessed pulse oximeter sensors.

Primary Outcome Measures

Name	Time	Method
Accuracy of Sensor by Arms Calculation	1-2 hours	Percentage of SpO2 (oxygen saturation by pulse oximetry) measured by the Reprocessed Oximeter pulse oximetry sensors during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. Accuracy root mean square (ARMS) between measured SpO2 and reference SaO2 (arterial oxygen saturation) must meet the 3% specification for each reprocessed pulse oximetry sensor style. Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square error (Arms) value. Standard deviation of the differences is computed as the precision. Square root of the sum of the squares of bias and precision is computed as the Arms Error value.

Secondary Outcome Measures